Group One Trading
MRVI icon

Group One Trading’s Maravai LifeSciences MRVI Stock Holding History

Group One Trading’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$583K Buy
93,400
+57,000
+157% +$246K ﹤0.01% 3347
2026
Q1 		$103K Sell
36,400
-338,000
-90% -$1.15M ﹤0.01% 4695
2025
Q4 		$1.22M Buy
374,400
+140,400
+60% +$473K ﹤0.01% 2723
2025
Q3 		$672K Buy
234,000
+117,700
+101% +$301K ﹤0.01% 3410
2025
Q2 		$280K Buy
116,300
+49,600
+74% +$104K ﹤0.01% 3991
2025
Q1 		$147K Buy
66,700
+42,400
+174% +$168K ﹤0.01% 4265
2024
Q4 		$132K Buy
24,300
+400
+2% +$2.57K ﹤0.01% 4280
2024
Q3 		$199K Buy
23,900
+7,700
+48% +$66.6K ﹤0.01% 3619
2024
Q2 		$116K Buy
16,200
+1,400
+9% +$12.1K ﹤0.01% 3850
2024
Q1 		$128K Sell
14,800
-1,600
-10% -$10.8K ﹤0.01% 3924
2023
Q4 		$107K Sell
16,400
-4,100
-20% -$26.5K ﹤0.01% 4406
2023
Q3 		$205K Sell
20,500
-32,000
-61% -$351K ﹤0.01% 3778
2023
Q2 		$653K Buy
52,500
+44,300
+540% +$598K ﹤0.01% 2755
2023
Q1 		$115K Buy
8,200
+6,800
+486% +$97.7K ﹤0.01% 4185
2022
Q4 		$20K Sell
1,400
-2,200
-61% -$34.6K ﹤0.01% 5596
2022
Q3 		$92K Buy
3,600
+3,400
+1,700% +$85.3K ﹤0.01% 4848
2022
Q2 		$6K Sell
200
-45,400
-100% -$1.44M ﹤0.01% 7004
2022
Q1 		$1.61M Buy
45,600
+41,800
+1,100% +$1.4M ﹤0.01% 2616
2021
Q4 		$159K Sell
3,800
-5,400
-59% -$219K ﹤0.01% 5305
2021
Q3 		$452K Buy
9,200
+6,700
+268% +$327K ﹤0.01% 4307
2021
Q2 		$104K Sell
2,500
-8,300
-77% -$322K ﹤0.01% 5908
2021
Q1 		$385K Sell
10,800
-8,800
-45% -$292K ﹤0.01% 4340
2020
Q4 		$550K Buy
+19,600
New +$546K ﹤0.01% 3180

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Group One Trading's MRVI Position: Q2 2026 in Review

Group One Trading sold out of Maravai LifeSciences (MRVI) in Q2 2026, closing a stake of 9,653 shares — an estimated $41.7K sold.

Group One Trading first reported a position in MRVI in Q2 2022 and held it in 11 quarters. The position peaked at $1.92M in Q2 2023. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Group One Trading reported no remaining Maravai LifeSciences position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 9,653 Maravai LifeSciences shares in Q2 2026, an estimated $41.7K.
  • Group One Trading first reported a position in Maravai LifeSciences in Q2 2022 and held it in 11 quarters.
  • Group One Trading's Maravai LifeSciences position peaked at $1.92M in Q2 2023.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.